How many components for the metabolic syndrome? Results of exploratory factor analysis in the FIBAR study

被引:26
作者
Mannuicci, E. [1 ,2 ]
Monami, M. [2 ]
Rotella, C. M. [1 ]
机构
[1] Univ Florence, Dept Clin Pathophysiol, Endocrinol Sect, I-50139 Florence, Italy
[2] Univ Florence, Crit Care Dept, Geriatr Unit, I-50139 Florence, Italy
关键词
metabolic syndrome; exploratory factor analysis; hyperuricaemia; glucose intolerance; INSULIN-RESISTANCE; URIC-ACID; GLUCOSE; DISEASE; RISK;
D O I
10.1016/j.numecd.2006.09.003
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Background and aims: Factor analysis can be used as a basis for the determination of diagnostic criteria for the metabolic syndrome (MS). This approach can be used as a basis for the determination of diagnostic criteria for MS. Methods and results: Exploratory factor analysis of Adult Treatment Panel (ATP)-III and International Diabetes Federation (IDF) criteria for MS, entered as dichotomic variables, was performed on 2945 patients enrolled in a screening programme for diabetes. The ability of calculated factors to identify patients with MS-related conditions (glucose intolerance, hyperuricaemia, and elevation of alanine aminotransferase; ALT) was assessed through Receiver Operator Characteristics (ROC) curve analysis. Alternative sets of criteria based on ATP-III and OF definitions of MS were also assessed. A two-factor structure was found for both ATP-III and IDF criteria. Factor 1 (associated with fasting hyperglycaemia, hypertension, and elevated waist circumference) was capable of identifying subjects with MS-related conditions to a greater extent than factor 2 (low HDL-chotesterol and hypertriglyceridaemia). When a composite variable (low HDL-cholesterol and/or hypertriglyceridaemia) was used for dislipidaemia, a single factor structure was obtained both for ATP-III and IDF definitions; this factor structure was retained when hyperuricaemia was added as a fifth component of MS. Such a modified definition of MS was not inferior to original ATP-III and IDF criteria in the identification of subjects with glucose intolerance and elevated ALT. Conclusions: A modification of current ATP-III or OF criteria is necessary in order to obtain a single-factor structure. Alternative definitions of MS, including additional features, such as hyperuricaemia, can maintain a monofactorial structure, and an association with related conditions not inferior to that of original criteria. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:719 / 726
页数:8
相关论文
共 24 条
[1]
The metabolic syndrome - a new worldwide definition [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
LANCET, 2005, 366 (9491) :1059-1062
[2]
Features of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance - A prospective study in mauritius [J].
Boyko, EJ ;
de Courten, M ;
Zimmet, PZ ;
Chitson, P ;
Tuomilehto, J ;
Alberti, KGMM .
DIABETES CARE, 2000, 23 (09) :1242-1248
[3]
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms [J].
Bugianesi, E ;
Gastaldelli, A ;
Vanni, E ;
Gambino, R ;
Cassader, M ;
Baldi, S ;
Ponti, V ;
Pagano, G ;
Ferrannini, E ;
Rizzetto, M .
DIABETOLOGIA, 2005, 48 (04) :634-642
[4]
Chalmers J, 1999, CLIN EXP HYPERTENS, V21, P1009
[5]
Choudhury J, 2005, FRONT BIOSCI-LANDMRK, V10, P1520
[6]
Analysis of the relationship between fasting serum uric acid and the insulin sensitivity index in a population-based sample of 380 young healthy Caucasians [J].
Clausen, JO ;
Borch-Johnsen, K ;
Ibsen, H ;
Pedersen, O .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1998, 138 (01) :63-69
[7]
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[8]
CONEN D, 2004, BMC PUBLIC HEALTH, V49, P155
[9]
Medical progress: Polycystic ovary syndrome [J].
Ehrmann, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (12) :1223-1236
[10]
Components of the "metabolic syndrome" and incidence of type 2 diabetes [J].
Hanson, RL ;
Imperatore, G ;
Bennett, PH ;
Knowler, WC .
DIABETES, 2002, 51 (10) :3120-3127